2010
DOI: 10.1016/s1569-1993(10)60241-x
|View full text |Cite
|
Sign up to set email alerts
|

Hyaluronic acid in the prevention of bronchial obstruction induced by hypertonic saline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…(11)(12)(13)(14)(15) Single-dose studies have also shown that when HA is added to HS, it also improves the latter's tolerability. (16)(17)(18) In the present study, we tested our hypothesis that a formulation of HS with HA could be better tolerated than HS alone when given twice daily for 28 days to a group of patients who had previously shown intolerance to HS.…”
Section: Introductionmentioning
confidence: 99%
“…(11)(12)(13)(14)(15) Single-dose studies have also shown that when HA is added to HS, it also improves the latter's tolerability. (16)(17)(18) In the present study, we tested our hypothesis that a formulation of HS with HA could be better tolerated than HS alone when given twice daily for 28 days to a group of patients who had previously shown intolerance to HS.…”
Section: Introductionmentioning
confidence: 99%
“…A spirometry was performed pre-and postbronchodilator and again 5 minutes after completing the inhalation. (29) Participants with inhalation-induced bronchospasm (fall ‡12% FEV 1 ) (30) were not allowed to continue the remainder sessions of the same treatment arm; however, they continued the study trying the next saline solution according to the same schedule and procedure.…”
Section: Outcome Measuresmentioning
confidence: 99%
“…Исследования по применению даже однократной дозы продемонстрировали, что добавление 0,1% рас-твора гиалуроновой кислоты к гипертоническому раст-вору значительно повышает переносимость препарата [10][11][12]. Особенно эффективны подобные ингаляции у пациентов с бронхоэктазами, врожденными пороками развития бронхов и при муковисцидозе.…”
Section: нарушение мукоцилиарного клиренса при хронических болезнях лunclassified